Consolidated Condensed Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,103,315	$ 1,601,660
Prepaid expenses and other	611,786	475,807
Total current assets	1,715,101	2,077,467
Other non-current assets:
Research and development supplies	1,847,412	2,046,858
Total other assets	1,847,412	2,046,858
Total assets	3,562,513	4,124,325
Current liabilities:
Accounts payables	1,619,446	1,074,295
Other current liabilities	932,260	1,429,875
Total current liabilities	2,551,706	2,504,170
Non-current liabilities:
Derivative liabilities	243,000	0
Total liabilities	2,794,706	2,504,170
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	0	0
Common stock $0.001 par value: 200,000,000 shares authorized; 1,004,247 and 217,234 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	1,004	217
Additional paid-in capital	168,004,988	156,419,381
Accumulated deficit	(167,238,185)	(154,799,443)
Total stockholders’ equity	767,807	1,620,155
Total liabilities and stockholders’ equity	$ 3,562,513	$ 4,124,325